Timothy J Scannell
CIK 1451533 · President and COO · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SYK price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
115
WAYNE, PA 19087
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NVCR | Director | 25,898 | $13.15 | $340.6K | -$86.8K | 8 | 2026-06-05 |
| PODD | Director | 33,024 | $149.68 | $4.94M | -$2.97M | 16 | 2026-05-21 |
| MASIMO CORP (MASI) Delisted | Director | 2,608 | $179.95 | $469.3K | $0 | 3 | 2026-05-05 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 5,694 | $104.91 | $597.4K | $0 | 1 | 2023-11-01 |
| Molekule Group, Inc. (AERC) Delisted | Director | — | $3.40 | — | $0 | 2 | 2022-06-09 |
| SYK | President and COO | 227,083 | $291.86 | $66.28M | -$17.48M | 54 | 2021-08-03 |
Recent Filings · Page 2 of 9
88 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-09-11 | PODD | Sell (S) | −5,000 | -$1.13M | EDGAR |
| 2024-09-10 | PODD | Notice (144) | −5,000 | -$1.13M | EDGAR |
| 2024-06-11 | PODD | Sell (S) | −7,000 | -$1.33M | EDGAR |
| 2024-06-10 | PODD | Notice (144) | −7,000 | -$1.33M | EDGAR |
| 2024-06-06 | NVCR | Mixed | +3,089 | -$23.0K | EDGAR |
| 2024-05-29 | PODD | Mixed | +14,967 | -$6.4K | EDGAR |
| 2024-05-28 | PODD | Notice (144) | −3,300 | -$597.0K | EDGAR |
| 2024-05-23 | PODD | Grant (A) | +1,380 | $0 | EDGAR |
| 2023-11-01 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,694 | $0 | EDGAR |
| 2023-06-09 | NVCR | Grant (A) | +3,853 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.